EUVIMEDEUVIMED entdecken
Crossref

Long-Term Outcomes and Prognostic Factors After Yttrium-90 Resin-Based Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma: A Single-Center Experience

Lorenzo Braccischi, Paolo Federico Garducci, Makoto Taninokuchi Tomassoni, Andrea Palloni, Sara Zanella, Giuseppe Della Gala, Lidia Strigari, Arber Golemi, Elisa Lodi Rizzini, Antonio De Cinque, Francesco Modestino, Giovanni Brandi und 1 weitere

CardioVascular and Interventional Radiology · 2025

DOI: 10.1007/s00270-025-04262-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift CardioVascular and Interventional Radiology, 2025. Verfasst von Lorenzo Braccischi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40136, Bologna, Italy. lorenzo.braccischi2@unibo.it. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Yttrium Radioisotopes, Bile Duct Neoplasms, Embolization, Therapeutic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: This study aimed to evaluate the long-term efficacy, safety, and prognostic factors associated with transarterial radioembolization with yttrium-90 (Y90-TARE) in unresectable intrahepatic cholangiocarcinoma (ICC). MATERIALS AND METHODS: We retrospectively analyzed 72 patients with unresectable ICC treated with Y90 resin microspheres TARE between 2009 and 2023. Clinical, laboratory, and imaging data were collected. Treatment response was assessed using RECIST 1.1 criteria. Primary outcome measures were overall survival (OS) and progression-free survival (PFS), evaluated through Kaplan-Meier analysis and Cox proportional hazards models. Secondary outcome measures included radiologic response and safety, with adverse events graded according to CIRSE grading system. RESULTS: Twenty-eight of 72 (38.9%) patients had monofocal tumors, and 45/72 (62.5%) had a tumor burden < 25%. The median index tumor diameter was 6.9 cm (IQR, 3.8-8.2 cm). Median OS and PFS were 17 (95% CI 13.15-20.57) and 7.5 months (95% CI 5.00-9.50), respectively. Target lesion objective response (OR) rate was 40.3%, overall OR was 36.1%. At multivariate analysis, independent predictors of improved OS were lower tumor volume (p = 0.011), TARE as first line (p < 0.001), and selective infusion target (p = 0.012). Monolobar disease (p = 0.010) and selective infusion target (p = 0.029) emerged as independent predictors of longer PFS. TARE as first line (p = 0.062) showed a trend toward significance in multivariable model. TARE was well tolerated, with no major complications observed. CONCLUSION: TARE is a safe and effective treatment for unresectable ICC. Selective infusion, lower tumor load, and administering TARE as first line-with or without concomitant chemotherapy-are independent predictors for prolonged OS and PFS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaYttrium RadioisotopesBile Duct NeoplasmsEmbolization, TherapeuticHumansMaleFemaleRetrospective StudiesMiddle AgedAgedPrognosisTreatment OutcomeMicrospheresRadiopharmaceuticals

Stichwörter der Autor:innen

Intrahepatic cholangiocarcinomaLiverResin spheresSelective internal radiation therapyTransarterial radioembolizationYttrium-90

Substanzen

Yttrium RadioisotopesYttrium-90Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40136, Bologna, Italy. lorenzo.braccischi2@unibo.it.
  • Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40136, Bologna, Italy.
  • Department of Radiology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, 40138, Bologna, Italy.
  • Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.
  • Department of Medical Physics, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, 40138, Bologna, Italy.
  • Radiation Oncology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, 40138, Bologna, Italy.

Zitieren

APA

Braccischi, L., Garducci, P. F., Taninokuchi Tomassoni, M., Palloni, A., Zanella, S., Della Gala, G., Strigari, L., Golemi, A., Lodi Rizzini, E., De Cinque, A., Modestino, F., Brandi, G., & Mosconi, C. (2025). Long-Term Outcomes and Prognostic Factors After Yttrium-90 Resin-Based Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma: A Single-Center Experience. CardioVascular and Interventional Radiology. https://doi.org/10.1007/s00270-025-04262-w

Vancouver

Braccischi L, Garducci PF, Taninokuchi Tomassoni M, Palloni A, Zanella S, Della Gala G, et al. Long-Term Outcomes and Prognostic Factors After Yttrium-90 Resin-Based Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma: A Single-Center Experience. CardioVascular and Interventional Radiology. 2025. doi:10.1007/s00270-025-04262-w

BibTeX
@article{Braccischi2025,
  author = {Braccischi, Lorenzo and Garducci, Paolo Federico and Taninokuchi Tomassoni, Makoto and Palloni, Andrea and Zanella, Sara and Della Gala, Giuseppe and Strigari, Lidia and Golemi, Arber and Lodi Rizzini, Elisa and De Cinque, Antonio and Modestino, Francesco and Brandi, Giovanni and Mosconi, Cristina},
  title = {Long-Term Outcomes and Prognostic Factors After Yttrium-90 Resin-Based Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma: A Single-Center Experience},
  journal = {CardioVascular and Interventional Radiology},
  year = {2025},
  doi = {10.1007/s00270-025-04262-w}
}
Kostenlos starten →